Displaying drugs 10876 - 10900 of 12647 in total
Tirilazad
Tirilazad has been used in trials studying the treatment of Spinal Cord Injury.
Investigational
Matched Description: … Tirilazad has been used in trials studying the treatment of Spinal Cord Injury. …
LY-2811376
LY2811376 has been used in trials studying the basic science of Alzheimer's Disease.
Investigational
Matched Description: … LY2811376 has been used in trials studying the basic science of Alzheimer's Disease. …
AZD-7325
AZD7325 is a high affinity, selective modulator of the GABAA receptor system.
Investigational
Matched Description: … AZD7325 is a high affinity, selective modulator of the GABAA receptor system. [L2936] …
TNG908
TNG908 is a small molecule inhibitor of protein arginine methyl transferase 5 (PRMT5).
Investigational
Matched Description: … TNG908 is a small molecule inhibitor of protein arginine methyl transferase 5 (PRMT5). …
Human Embryonic Stem Cell-derived M Cell
CAStem is composed of immunity- and matrix-regulatory cells (IMRCs), also known as M cells, which can be administered through injection. These IMRCs are differentiated from human embryonic stem cells that are expanded and then harvested. These cells are currently being investigated against lung injury and fibrosis -- conditions which are...
Investigational
Matched Description: … CAStem is composed of immunity- and matrix-regulatory cells (IMRCs), also known as M cells, which can ... are currently being investigated against lung injury and fibrosis -- conditions which are outcomes of ... IMRCs are similar to MSCs in terms of their capacity for self-renewal and tri-lineage differentiation …
ATX-914
Axt914 is under investigation in clinical trial NCT00417261 (Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of Single and Multiple-Doses of ATF936 and AXT914 Administered Orally in Healthy Subjects.).
Investigational
Matched Description: … Single and Multiple-Doses of ATF936 and AXT914 Administered Orally in Healthy Subjects.). ... investigation in clinical trial NCT00417261 (Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of …
Adriforant
Adriforant is under investigation in clinical trial NCT00992342 (A Phase 1 Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03893787 In Healthy Adult Volunteers).
Investigational
Matched Description: … Different Doses Of PF-03893787 In Healthy Adult Volunteers). ... investigation in clinical trial NCT00992342 (A Phase 1 Study To Evaluate The Safety And Tolerability Of …
Exebacase
Exebacase is under investigation in clinical trial NCT03163446 (Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia).
Investigational
Matched Description: … Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia). ... Exebacase is under investigation in clinical trial NCT03163446 (Safety, Efficacy and Pharmacokinetics of …
Nanrilkefusp alfa
Nanrilkefusp alfa is a human fusion protein consisting of the cytokine interleukin (IL)-15 and the high-affinity binding sushi+ domain of IL-15 receptor alpha (IL-15Ra).
Investigational
Matched Description: … binding sushi+ domain of IL-15 receptor alpha (IL-15Ra). ... Nanrilkefusp alfa is a human fusion protein consisting of the cytokine interleukin (IL)-15 and the high-affinity …
R1204
R1204 is G-protein-coupled receptor modulator. It is developed for the treatment of depression.
Investigational
Matched Description: … It is developed for the treatment of depression. …
Atacicept
Atacicept is a recombinant fusion protein combined with the extracellular ligand binding portion of TACI.
Investigational
Matched Description: … Atacicept is a recombinant fusion protein combined with the extracellular ligand binding portion of TACI …
Dapivirine
Dapivirine has been investigated for the prevention of HIV-1 Infections and Topical Penile Exposures.
Investigational
Matched Description: … Dapivirine has been investigated for the prevention of HIV-1 Infections and Topical Penile Exposures. …
Solanezumab
Solanezumab is under investigation for the treatment of Dementia, Alzheimers Disease, and Alzheimers Disease, Familial.
Investigational
Matched Description: … Solanezumab is under investigation for the treatment of Dementia, Alzheimers Disease, and Alzheimers …
Idalopirdine
Idalopirdine has been used in trials studying the treatment of Cognition, Schizophrenia, and Alzheimer's Disease.
Investigational
Matched Description: … Idalopirdine has been used in trials studying the treatment of Cognition, Schizophrenia, and Alzheimer's …
Ulinastatin
Ulinastatin has been investigated for the prevention of Cardiovascular Disease and Adverse Reaction to Drug.
Investigational
Matched Description: … Ulinastatin has been investigated for the prevention of Cardiovascular Disease and Adverse Reaction to …
Zamicastat
Zamicastat has been used in trials studying the treatment of Hypertension and Chronic Heart Failure.
Investigational
Matched Description: … Zamicastat has been used in trials studying the treatment of Hypertension and Chronic Heart Failure. …
Calcitonin eel
HC-58 has been used in trials studying the prevention of Severe Upper Limb Hemiplegia.
Investigational
Matched Description: … HC-58 has been used in trials studying the prevention of Severe Upper Limb Hemiplegia. …
Urocortin-2
Urocortin 2 has been investigated for the basic science of Heart Failure and Cardiovascular Disease.
Investigational
Matched Description: … Urocortin 2 has been investigated for the basic science of Heart Failure and Cardiovascular Disease. …
Thyrotropin
Thyrotropin is under investigation in clinical trial NCT01348191 (Detection of Thyrotrophin Receptor in Human Myometrium).
Investigational
Matched Description: … Thyrotropin is under investigation in clinical trial NCT01348191 (Detection of Thyrotrophin Receptor …
Petesicatib
Petesicatib is under investigation in clinical trial NCT02295332 (A Study of RG7625 in Healthy Volunteers).
Investigational
Matched Description: … Petesicatib is under investigation in clinical trial NCT02295332 (A Study of RG7625 in Healthy Volunteers …
KW-6356
KW-6356 is a selective antagonist of adenosine A2A receptors developed by Kyowa Kirin.
Experimental
Matched Description: … KW-6356 is a selective antagonist of adenosine A2A receptors developed by Kyowa Kirin.[L43822] …
Zafiride
Zafiride is a human tumor necrosis factor coupled to the C terminus of CNGRCG peptide.
Investigational
Matched Description: … Zafiride is a human tumor necrosis factor coupled to the C terminus of CNGRCG peptide. …
KT-253
KT-253 is a selective heterobifunctional small molecule degrader of mouse double minute 2 (MDM2).
Investigational
Matched Description: … KT-253 is a selective heterobifunctional small molecule degrader of mouse double minute 2 (MDM2). …
PRG-A01
PRG-A01 is a novel inhibitor of Cu, Zn-superoxide dismutase (SOD1) misfolding and aggregation.
Investigational
Matched Description: … PRG-A01 is a novel inhibitor of Cu, Zn-superoxide dismutase (SOD1) misfolding and aggregation. …
AT1022
AT1022 is a hydromorphone skin patch designed to provide rapid and sustained delivery of a potent opiate for the management of severe pain.
AT1022 incorporates PassPort(TM) system, developed to deliver protein and peptide drugs, small-molecule drugs, genes and vaccines across the skin for local and systemic effect.
Investigational
Matched Description: … for the management of severe pain. ... AT1022 is a hydromorphone skin patch designed to provide rapid and sustained delivery of a potent opiate …
Displaying drugs 10876 - 10900 of 12647 in total